Delivery Order SPE2DB25D3109-SPE2DB25FPKTS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,609.85 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This competitively awarded, firm fixed-price delivery order is set to be completed by August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used in the management of hyperkalemia, a condition relevant to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Veltassa 8.4 GM Powder Packet in a quantity of 30 units, with a ceiling value of $2,716.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM Powder Packet in quantities of 30, with a contract value of $8,148.60. Veltassa is a pharmaceutical treatment used in potassium management. This competitively awarded, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,424.40 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded transaction. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding agent used in the...
- The Defense Logistics Agency awarded a $4,074.30 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veltassa 8.4 GM powder packets (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,988.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count). This is a non-set-aside contract with performance at the contractor's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of September 12, 2025. Veltassa is a potassium-binding pharmaceutical used in the management of hyperkalemia, a common concern in military and...
- The Defense Logistics Agency awarded a $7,533.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood....
- The Defense Logistics Agency awarded a $3,083.67 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for Veltassa 8.4 gm powder packets (30-count). This competitively awarded, firm fixed-price order is classified as a child contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Veltassa 8.4 GM Powder Packet (30-count) with a ceiling value of $1,358.10. This is a firm fixed price delivery order with no set-aside designation, meaning the award was made through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,202.32 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPKTSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units) with a ceiling value of $1,358.10. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition requiring careful medical management particularly relevant to military and veteran healthcare populations. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contracting portfolio demonstrates substantial capability in distributing specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/14/25 |